BMC Infectious Diseases

《BMC Infectious Diseases》是 2001 年创刊的开放获取期刊，由 BioMed Central 出版，现属施普林格·自然旗下。

刊物覆盖人类与动物感染性疾病以及性传播疾病的预防、诊断与管理，兼及相关的分子遗传学、病理生理学与流行病学。

2025 年期刊影响因子为 3.2，五年影响因子为 3.3，在传染病学 141 种期刊中排第 55 位。

Scope

• Bacterial and fungal diseases form a large part of the journal, from laboratory characterisation to clinical management.细菌与真菌疾病占据刊物的大部分篇幅，从实验室鉴定一直写到临床处置。
• Healthcare-associated infection control papers examine surveillance, outbreak response and stewardship of antimicrobials.医疗相关感染控制论文考察监测、暴发应对与抗菌药物管理。
• Hepatitis and co-infection studies address viral load, treatment access and outcomes in mixed infections.肝炎与合并感染研究处理病毒载量、治疗可及性以及混合感染下的结局。
• HIV research spans prevention, antiretroviral therapy, drug resistance and comorbidity with other infections.HIV 研究覆盖预防、抗逆转录病毒治疗、耐药以及与其他感染的共病。
• Parasitological diseases are reported from endemic settings and from returning travellers.寄生虫病既有来自地方性流行区的报告，也有从旅行者归国后发现的病例。
• Sexually transmitted infections are studied through screening programmes, partner notification and behavioural surveillance.性传播感染通过筛查项目、伴侣通知与行为监测加以研究。
• Tuberculosis and other mycobacterial diseases attract work on diagnosis, regimen design and programmatic delivery.结核与其他分枝杆菌疾病吸引诊断、方案设计与规划实施方面的研究。
• Vaccine papers cover immunogenicity, field effectiveness and implementation in low-resource settings.疫苗论文涉及免疫原性、现场效果以及在资源匮乏地区的推行。
• Viral diseases range from respiratory and enteric infections to haemorrhagic fevers and emerging pathogens.病毒性疾病从呼吸道与肠道感染延伸到出血热和新发病原体。
• Diagnostic studies evaluate molecular assays, point-of-care tests and imaging in infection.诊断研究评估分子检测、即时检验与感染影像学。
• Antimicrobial resistance surveillance and stewardship interventions are a recurring theme.耐药监测与抗菌药物管理干预是反复出现的主题。
• Outbreak investigations and surveillance systems describe transmission chains and control measures.暴发调查与监测体系描述传播链和控制措施。
• Clinical management papers report treatment outcomes, complications and prognostic markers.临床管理论文报告治疗结局、并发症与预后标志物。
• Infection in immunocompromised hosts and transplant recipients receives separate attention.免疫抑制宿主与移植受者的感染受到单独关注。
• Zoonoses and One Health studies link veterinary, environmental and human health data.人畜共患病与同一健康研究把兽医、环境与人类健康数据连接起来。
• Mathematical modelling and genomic epidemiology papers trace spread and evaluate interventions.数学建模与基因组流行病学论文追踪传播并评估干预。
• Molecular genetics and pathophysiology studies underpin the journal's laboratory section.分子遗传学与病理生理研究支撑刊物的实验室部分。
• Study protocols and systematic reviews are considered when they address a defined clinical or public health question.研究方案与系统综述若能回答明确的临床或公共卫生问题，也会被考虑。

• Infection prevention in surgery and critical care is examined through bundle audits and device-associated infection rates.外科与重症监护中的感染预防通过集束化措施审核与器械相关感染率加以考察。
• Paediatric and maternal infections receive attention, including neonatal sepsis and congenital transmission.儿科与孕产妇感染受到关注，包括新生儿败血症与母婴垂直传播。

History

• The journal was launched in 2001 by BioMed Central, the online open-access publisher founded in London.刊物于 2001 年由总部设在伦敦的在线开放获取出版商 BioMed Central 创办。
• It belongs to the BMC series, a family of subject journals that share editorial policies and a submission system.刊物属于 BMC 系列，这一期刊群共用编辑政策与投稿系统。
• Articles are published continuously and gathered into an annual volume rather than discrete issues.论文连续发表，按年度汇成一卷，而不分成若干期。
• The title is indexed in MEDLINE and PubMed, Science Citation Index Expanded, Scopus and the Directory of Open Access Journals.刊物被 MEDLINE 与 PubMed、科学引文索引扩展版、Scopus 以及开放获取期刊目录收录。
• Impact factor history runs 3.09 in 2021, 3.667 in 2022, 3.4 in 2023, 3.0 in 2024 and 3.2 in 2025.影响因子历年数值为 2021 年 3.09、2022 年 3.667、2023 年 3.4、2024 年 3.0 与 2025 年 3.2。
• The 2025 five-year impact factor is 3.3.2025 年五年影响因子为 3.3。
• In 2025 the journal ranks 55 of 141 in Infectious Diseases, in the second quartile at the 61st percentile.2025 年刊物在传染病学 141 种期刊中列第 55 位，处于第二四分位，百分位为 61。
• The 2025 window recorded 35197 citations to 1819 articles, with 2000 citable items.2025 年统计窗口记录 35197 次引用，施引对象为 1819 篇论文，可被引条目 2000 项。
• Almost all recent content is gold open access, at 99.98 percent.近年内容几乎全部以金色开放获取方式发表，比例为 99.98%。
• The median time from submission to first decision is seven days.从投稿到首次决定的中位时间为七天。
• The journal recorded 13.2 million downloads in 2025.2025 年刊物下载量达到 1320 万次。
• With the BMC portfolio, the title moved to Springer Nature Link, where its archive and submission pages now sit.随着 BMC 期刊群迁转，刊物移至施普林格·自然链接平台，过刊与投稿页面均设于该处。
• Publication is funded through an article processing charge rather than subscriptions.出版经费来自文章处理费，而非订阅收入。
• Article collections have gathered work on Lyme borreliosis, emerging zoonoses and antimicrobial resistance.文章合集曾汇集莱姆病、新发人畜共患病与耐药方面的研究。
• More than half of the articles published in 2025 were linked to one or more of the United Nations Sustainable Development Goals.2025 年发表的论文中有一半以上与联合国可持续发展目标中的一项或多项相关。

• The journal has published thematic collections on antimicrobial stewardship and on diagnostics for resource-limited laboratories.刊物曾推出抗菌药物管理与资源匮乏实验室诊断方面的专题合集。

Editors

• Natasha Hirst is the lead editor, based at Springer Nature in London.主编 Natasha Hirst 任职于伦敦的施普林格·自然。
• Hirst holds an MSc and a PhD in parasitology and joined the journal in June 2023 after editing at The FEBS Journal.Hirst 拥有寄生虫学硕士与博士学位，2023 年 6 月加入本刊，此前在 The FEBS Journal 从事编辑工作。
• Stefan Baral, a physician epidemiologist at Johns Hopkins University, sits on the senior editorial board.约翰斯·霍普金斯大学的医师流行病学家 Stefan Baral 在高级编委会任职。
• Eleonora Cella, of the Burnett School of Biomedical Sciences at the University of Central Florida, is a senior board member.中佛罗里达大学伯内特生物医学学院的 Eleonora Cella 是高级编委。
• Ka Chun Chong, at the Chinese University of Hong Kong, brings health systems and policy research to the senior board.香港中文大学的 Ka Chun Chong 为高级编委会带来卫生体系与政策研究视角。
• Rodrigo Feliciano do Carmo, of the Federal University of the São Francisco Valley in Brazil, is a senior board member.巴西圣弗朗西斯科河谷联邦大学的 Rodrigo Feliciano do Carmo 担任高级编委。
• Ursula Panzner, at Ludwig Maximilian University of Munich, works on global public health and parasitology.慕尼黑大学的 Ursula Panzner 从事全球公共卫生与寄生虫学研究。
• Carlo Torti, of the Università Cattolica del Sacro Cuore in Milan, covers clinical infectious diseases.米兰圣心天主教大学的 Carlo Torti 负责临床传染病方向。
• Livia Melo Villar, at FIOCRUZ in Rio de Janeiro, heads a reference centre for viral hepatitis.里约热内卢奥斯瓦尔多·克鲁兹基金会的 Livia Melo Villar 主持病毒性肝炎参比中心。
• Associate editors based in Pune handle manuscript assessment and reviewer selection.常驻浦那的副编辑负责稿件评估与审稿人选择。
• Assistant editors in the same office manage correspondence and production checks.同一办公室的助理编辑处理往来信函与出版前核查。
• The wider editorial board draws members from Bahrain, Qatar, Australia, Egypt, South Korea and other countries.更广泛的编委会成员来自巴林、卡塔尔、澳大利亚、埃及与韩国等地。
• Editorial advisors provide a further layer of specialist opinion on contentious submissions.顾问编辑对有争议的稿件提供又一层专业意见。
• Manuscripts are submitted through the Springer Nature portal and assigned to an editor by subject.稿件经施普林格·自然投稿门户提交，并按学科分派给编辑。
• Board expertise spans bacteriology, virology, mycology, parasitology, tuberculosis, HIV and vaccinology.编委专长涵盖细菌学、病毒学、真菌学、寄生虫学、结核、HIV 与疫苗学。
• Section expertise also covers infection control, clinical microbiology and public health surveillance.编委专长还覆盖感染控制、临床微生物学与公共卫生监测。
• Each manuscript is screened for scope before assignment, and out-of-scope papers are returned quickly.每篇稿件在分派前先做范围审查，超出范围的论文会被迅速退回。